Fredun Pharmaceuticals reports over 90% revenue and profit surge in Q1 FY27 as diversified healthcare strategy gains momentum

Fredun Pharmaceuticals reveals a dramatic 90% increase in revenue and nearly 95% rise in net profit in its Q1 FY27 results, driven by strategic diversification into new healthcare sectors and expansion in global markets. Fredun Pharmaceuticals said its unaudited first-quarter…















